News Releases

2010
2009
2008
2007
2006
2005
2004

 

November16, 2009 Protox Reports 2009 Third Quarter Results

 

October 29, 2009 Protox Presents Phase 2 BPH Data at the World Congress of the Societe Internationale D’Urologie

 

September 10, 2009 Protox Announces Positive 12 Month Phase 2 BPH Results

 

September 9, 2009 Protox to present at the 11th Annual Rodman & Renshaw Healthcare Conference

 

September 8, 2009 Protox Completes Enrollment of Phase 2B BPH Trial

 

August 14, 2009 Protox Reports 2009 Second Quarter Results
  June 29, 2009 Protox to Present Benign Prostatic Hyperplasia Data at Canadian Urology Conference
  June 16, 2009 Protox Appoints Dr. Alexander Giaquinto to Board of Directors
  May 20, 2009 Protox completes $2.31 million private placement
  May 15, 2009 Protox reports 2009 first quarter results
  April 29, 2009 Protox Presents BPH Data at the Annual American Urological Association Conference
  April 28, 2009 Protox Announces Private Placement
  March 26, 2009 Protox Reports 2008 Financial Results and Achievements
  March 23, 2009 Protox Appoints Chief Financial Officer
  January 12, 2009 Protox Announces Initiation of Placebo Controlled Phase 2 BPH Study

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39